VAXCELL-BIO THERAPEUTICSVV

VAXCELL-BIO THERAPEUTICS

9.320KRWD
−60−0,64%
Alla chiusura del 09:00 GMT
KRW
Nessun attività
Visualizza sui grafici
Indietro

Utile operativo su VAXCELL-BIO THERAPEUTICS.

Dati annuali
2019
2020
2021
2022
2023
2024
TTM
‪‪−16,00 B‬‬
‪‪−12,00 B‬‬
‪‪−8,00 B‬‬
‪‪−4,00 B‬‬
‪0,00‬
Periodo
Valore
Variazione
Variazione %
TTM
‪‪−15,03 B‬‬
‪0,00‬
‪0,00‬%
2024
‪‪−15,03 B‬‬
‪‪−3,52 B‬‬
‪−30,57‬%
2023
‪‪−11,51 B‬‬
‪‪−3,29 B‬‬
‪−40,12‬%
2022
‪‪−8,21 B‬‬
‪‪−2,31 B‬‬
‪−39,10‬%
2021
‪‪−5,90 B‬‬
‪‪−1,65 B‬‬
‪−38,76‬%
2020
‪‪−4,25 B‬‬
‪‪−244,25 M‬‬
‪−6,09‬%
2019
Dati trimestrali
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−4,40 B‬‬
‪‪−3,30 B‬‬
‪‪−2,20 B‬‬
‪‪−1,10 B‬‬
‪0,00‬
Periodo
Valore
Variazione
Variazione %
Q4 '24
‪‪−4,34 B‬‬
‪‪−810,07 M‬‬
‪−22,95‬%
Q3 '24
‪‪−3,53 B‬‬
+‪‪384,82 M‬‬
+‪9,83‬%
Q2 '24
‪‪−3,91 B‬‬
‪‪−672,56 M‬‬
‪−20,75‬%
Q1 '24
‪‪−3,24 B‬‬
‪‪−97,49 M‬‬
‪−3,10‬%
Q4 '23
‪‪−3,14 B‬‬
‪‪−50,61 M‬‬
‪−1,64‬%
Q3 '23
‪‪−3,09 B‬‬
‪‪−319,82 M‬‬
‪−11,53‬%
Q2 '23
‪‪−2,77 B‬‬
‪‪−278,74 M‬‬
‪−11,17‬%
Q1 '23
‪‪−2,50 B‬‬
+‪‪361,73 M‬‬
+‪12,66‬%
Q4 '22
Q3 '22
Q2 '22
Q1 '22
Q4 '21
Q3 '21
Q2 '21
Q1 '21
Q4 '20
Q3 '20
Q2 '20
Q1 '20